GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Icure Pharmaceutical Inc (XKRX:175250) » Definitions » Issuance of Debt

Icure Pharmaceutical (XKRX:175250) Issuance of Debt : ₩16,510 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Icure Pharmaceutical Issuance of Debt?

Icure Pharmaceutical's Issuance of Debt for the three months ended in Sep. 2024 was ₩-10 Mil.

Icure Pharmaceutical's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was ₩16,510 Mil.

Icure Pharmaceutical Issuance of Debt Historical Data

The historical data trend for Icure Pharmaceutical's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icure Pharmaceutical Issuance of Debt Chart

Icure Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77,332.00 13,700.00 52,500.00 9,000.00 21,451.60

Icure Pharmaceutical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,945.80 3,610.00 2,000.00 10,910.00 -10.00

Icure Pharmaceutical Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩16,510 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icure Pharmaceutical Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Icure Pharmaceutical's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Icure Pharmaceutical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Icure Pharmaceutical Inc (XKRX:175250) » Definitions » Issuance of Debt
Comparable Companies
XKRX:204840 XKRX:000220 XKRX:041910 XKRX:017180 XKRX:034940 XKRX:314140 XKRX:131030 XKRX:318010 XKRX:012790 XKRX:007370 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
7, Saimdang-ro 1-gil, Seocho-gu, Seoul, KOR
Website
https://www.icure.co.kr
Icure Pharmaceutical Inc operates as a biopharmaceutical company engages in the development and commercialization of novel transdermal drug delivery formulation. It also developed and commercialized various patches and hydrogels for the treatment of rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. The products pipeline is also aimed at the development of prescription drugs to diseases of the central nervous system, asthma, and pain.

Icure Pharmaceutical Headlines

No Headlines